Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Lenz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|January 11, 2008
Obesity: the hormonal milieuAnne Lenz, Frank B Diamond
JAMA Surgery|October 29, 2015
A Painless Mass in the Pancreas: Incidental FindingAnne Lenz, Alexander Brunner, Jürg Metzger
Pediatric Research|July 9, 2010
Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblastsAnne Lenz, Meghan Bennett, William P Skelton, et al.
European Journal of Clinical Investigation|April 1, 2010
Epidermal growth factor's activation of Ras is inhibited by four cardiac hormonesYing Sun, Ehrentraud J Eichelbaum, Anne Lenz, et al.
European Journal of Clinical Investigation|June 16, 2010
Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cellsWilliam P Skelton, Guillermo Pi, Anne Lenz, et al.
Anticancer Research|May 6, 2009
Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cellsYing Sun, Ehrentraud J Eichelbaum, William P Skelton, et al.
Anticancer Research|June 17, 2009
Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cellsYing Sun, Ehrentraud J Eichelbaum, Anne Lenz, et al.
In Vivo (Athens, Greece)|April 6, 2010
Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilatorAnne Lenz, Ying Sun, Ehrentraud J Eichelbaum, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Endocrinology, Diabetes, and Obesity|January 11, 2008
Obesity: the hormonal milieuAnne Lenz, Frank B Diamond
JAMA Surgery|October 29, 2015
A Painless Mass in the Pancreas: Incidental FindingAnne Lenz, Alexander Brunner, Jürg Metzger
Pediatric Research|July 9, 2010
Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblastsAnne Lenz, Meghan Bennett, William P Skelton, et al.
European Journal of Clinical Investigation|April 1, 2010
Epidermal growth factor's activation of Ras is inhibited by four cardiac hormonesYing Sun, Ehrentraud J Eichelbaum, Anne Lenz, et al.
European Journal of Clinical Investigation|June 16, 2010
Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cellsWilliam P Skelton, Guillermo Pi, Anne Lenz, et al.
Anticancer Research|May 6, 2009
Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cellsYing Sun, Ehrentraud J Eichelbaum, William P Skelton, et al.
Anticancer Research|June 17, 2009
Atrial natriuretic peptide and long-acting natriuretic peptide inhibit ras in human prostate cancer cellsYing Sun, Ehrentraud J Eichelbaum, Anne Lenz, et al.
In Vivo (Athens, Greece)|April 6, 2010
Twice-weekly intravenous treatment of pancreatic cancer with atrial natriuretic peptide and vessel dilatorAnne Lenz, Ying Sun, Ehrentraud J Eichelbaum, et al.
Pageof 1